Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Noninvasive imaging of in vivo MuRF1 expression during muscle atrophy.

Li W, Claypool MD, Friera AM, McLaughlin J, Baltgalvis KA, Smith IJ, Kinoshita T, White K, Lang W, Godinez G, Payan DG, Kinsella TM.

PLoS One. 2014 Apr 7;9(4):e94032. doi: 10.1371/journal.pone.0094032. eCollection 2014.

2.

Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.

Castillero E, Alamdari N, Lecker SH, Hasselgren PO.

Metabolism. 2013 Oct;62(10):1495-502. doi: 10.1016/j.metabol.2013.05.018. Epub 2013 Jul 15.

PMID:
23866982
3.

Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.

Baehr LM, Furlow JD, Bodine SC.

J Physiol. 2011 Oct 1;589(Pt 19):4759-76. doi: 10.1113/jphysiol.2011.212845. Epub 2011 Aug 1.

4.

UBE2D2 is not involved in MuRF1-dependent muscle wasting during hindlimb suspension.

Polge C, Koulmann N, Claustre A, Jarzaguet M, Serrurier B, Combaret L, Béchet D, Bigard X, Attaix D, Taillandier D.

Int J Biochem Cell Biol. 2016 Oct;79:488-493. doi: 10.1016/j.biocel.2016.06.019. Epub 2016 Jul 1.

PMID:
27378730
5.

Deletion of atrophy enhancing genes fails to ameliorate the phenotype in a mouse model of spinal muscular atrophy.

Iyer CC, McGovern VL, Wise DO, Glass DJ, Burghes AH.

Neuromuscul Disord. 2014 May;24(5):436-44. doi: 10.1016/j.nmd.2014.02.007. Epub 2014 Feb 25.

6.

Modulation of muscle atrophy, fatigue and MLC phosphorylation by MuRF1 as indicated by hindlimb suspension studies on MuRF1-KO mice.

Labeit S, Kohl CH, Witt CC, Labeit D, Jung J, Granzier H.

J Biomed Biotechnol. 2010;2010:693741. doi: 10.1155/2010/693741. Epub 2010 Jun 24.

7.

Branched-chain amino acids reduce hindlimb suspension-induced muscle atrophy and protein levels of atrogin-1 and MuRF1 in rats.

Maki T, Yamamoto D, Nakanishi S, Iida K, Iguchi G, Takahashi Y, Kaji H, Chihara K, Okimura Y.

Nutr Res. 2012 Sep;32(9):676-83. doi: 10.1016/j.nutres.2012.07.005. Epub 2012 Sep 17.

PMID:
23084640
8.

Altered gene expression patterns in muscle ring finger 1 null mice during denervation- and dexamethasone-induced muscle atrophy.

Furlow JD, Watson ML, Waddell DS, Neff ES, Baehr LM, Ross AP, Bodine SC.

Physiol Genomics. 2013 Dec 1;45(23):1168-85. doi: 10.1152/physiolgenomics.00022.2013. Epub 2013 Oct 15.

9.

NF-κB but not FoxO sites in the MuRF1 promoter are required for transcriptional activation in disuse muscle atrophy.

Wu CL, Cornwell EW, Jackman RW, Kandarian SC.

Am J Physiol Cell Physiol. 2014 Apr 15;306(8):C762-7. doi: 10.1152/ajpcell.00361.2013. Epub 2014 Feb 19.

10.

A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure.

Watson ML, Baehr LM, Reichardt HM, Tuckermann JP, Bodine SC, Furlow JD.

Am J Physiol Endocrinol Metab. 2012 May 1;302(10):E1210-20. doi: 10.1152/ajpendo.00512.2011. Epub 2012 Feb 21.

11.

Paradoxical effect of IKKβ inhibition on the expression of E3 ubiquitin ligases and unloading-induced skeletal muscle atrophy.

Belova SP, Shenkman BS, Kostrominova TY, Nemirovskaya TL.

Physiol Rep. 2017 Aug;5(16). pii: e13291. doi: 10.14814/phy2.13291.

12.

l-Carnitine supplement reduces skeletal muscle atrophy induced by prolonged hindlimb suspension in rats.

Jang J, Park J, Chang H, Lim K.

Appl Physiol Nutr Metab. 2016 Dec;41(12):1240-1247. Epub 2016 Aug 17.

PMID:
27841025
13.

Trichostatin A, a histone deacetylase inhibitor, modulates unloaded-induced skeletal muscle atrophy.

Dupré-Aucouturier S, Castells J, Freyssenet D, Desplanches D.

J Appl Physiol (1985). 2015 Aug 15;119(4):342-51. doi: 10.1152/japplphysiol.01031.2014. Epub 2015 Jun 25.

14.

During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation.

Cohen S, Brault JJ, Gygi SP, Glass DJ, Valenzuela DM, Gartner C, Latres E, Goldberg AL.

J Cell Biol. 2009 Jun 15;185(6):1083-95. doi: 10.1083/jcb.200901052. Epub 2009 Jun 8.

15.

mTORC1 promotes denervation-induced muscle atrophy through a mechanism involving the activation of FoxO and E3 ubiquitin ligases.

Tang H, Inoki K, Lee M, Wright E, Khuong A, Khuong A, Sugiarto S, Garner M, Paik J, DePinho RA, Goldman D, Guan KL, Shrager JB.

Sci Signal. 2014 Feb 25;7(314):ra18. doi: 10.1126/scisignal.2004809.

PMID:
24570486
16.

Targeting the ubiquitin E3 ligase MuRF1 to inhibit muscle atrophy.

Eddins MJ, Marblestone JG, Suresh Kumar KG, Leach CA, Sterner DE, Mattern MR, Nicholson B.

Cell Biochem Biophys. 2011 Jun;60(1-2):113-8. doi: 10.1007/s12013-011-9175-7.

PMID:
21448668
17.

The ChIP-seq-defined networks of Bcl-3 gene binding support its required role in skeletal muscle atrophy.

Jackman RW, Wu CL, Kandarian SC.

PLoS One. 2012;7(12):e51478. doi: 10.1371/journal.pone.0051478. Epub 2012 Dec 10.

18.

PGC-1α over-expression suppresses the skeletal muscle atrophy and myofiber-type composition during hindlimb unloading.

Wang J, Wang F, Zhang P, Liu H, He J, Zhang C, Fan M, Chen X.

Biosci Biotechnol Biochem. 2017 Mar;81(3):500-513. doi: 10.1080/09168451.2016.1254531. Epub 2016 Nov 21.

PMID:
27869526
19.

[Effect of Ligustrazine on expressions of FoXO3a, MAFbx, and MuRF1 in denervated skeletal muscle atrophy rats].

Wang H, Liang B, Peng C, Wang P.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012 May;26(5):597-600. Chinese.

PMID:
22702057
20.

Regulation of nicotinic acetylcholine receptor turnover by MuRF1 connects muscle activity to endo/lysosomal and atrophy pathways.

Rudolf R, Bogomolovas J, Strack S, Choi KR, Khan MM, Wagner A, Brohm K, Hanashima A, Gasch A, Labeit D, Labeit S.

Age (Dordr). 2013 Oct;35(5):1663-74. doi: 10.1007/s11357-012-9468-9. Epub 2012 Sep 6.

Supplemental Content

Support Center